Literature DB >> 17384136

Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen.

Eduard I Dedkov1, Wei Zheng, Lance P Christensen, Robert M Weiss, Florence Mahlberg-Gaudin, Robert J Tomanek.   

Abstract

We tested the hypothesis that chronically reducing the heart rate in infarcted middle-aged rats using ivabradine (IVA) would induce arteriolar growth and attenuate perivascular collagen and, thereby, improve maximal perfusion and coronary reserve in the surviving myocardium. Myocardial infarction (MI) was induced in 12-mo-old male Sprague-Dawley rats, which were then treated with either IVA (10.5 mg.kg(-1).day(-1); MI + IVA) or placebo (MI) via intraperitoneal osmotic pumps for 4 wk. Four weeks of IVA treatment limited the increase in left ventricular end-diastolic pressure and the decrease in ejection fraction but did not affect the size of the infarct, the magnitude of myocyte hypertrophy, or the degree of arteriolar and capillary growth. However, treatment reduced interstitial and periarteriolar collagen in the surviving myocardium of MI + IVA rats. The reduced periarteriolar collagen content was associated with improvement in maximal myocardial perfusion and coronary reserve. Although the rates of proliferation of periarteriolar fibroblasts were similar in the MI and MI + IVA groups, the expression levels of the AT(1) receptor and transforming growth factor (TGF)-beta(1) in the myocardium, as well as the plasma level of the ANG II peptide, were lower in treated rats 14 days after MI. Therefore, our data reveal that improved maximal myocardial perfusion and coronary reserve in MI + IVA rats are most likely the result of reduced periarteriolar collagen rather than enhanced arteriolar growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384136     DOI: 10.1152/ajpheart.00047.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  24 in total

Review 1.  Antifungal proteins: targets, mechanisms and prospective applications.

Authors:  T Theis; U Stahl
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

2.  Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.

Authors:  S Suffredini; F Stillitano; L Comini; M Bouly; S Brogioni; C Ceconi; R Ferrari; A Mugelli; E Cerbai
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Does ivabradine exhibit a role in the reduction of bladder overactivity?

Authors:  K Stamatiou; I Heretis; E Skoumbourdis
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 4.  Vascular endothelial ageing, heartbeat after heartbeat.

Authors:  Eric Thorin; Nathalie Thorin-Trescases
Journal:  Cardiovasc Res       Date:  2009-07-07       Impact factor: 10.787

5.  Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.

Authors:  Nicolas Couvreur; Renaud Tissier; Sandrine Pons; Valérie Chetboul; Vassiliky Gouni; Patrick Bruneval; Chantal Mandet; Jean-Louis Pouchelon; Alain Berdeaux; Bijan Ghaleh
Journal:  Eur Heart J       Date:  2009-12-21       Impact factor: 29.983

6.  Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy.

Authors:  J Finsterer; C Stöllberger; E Berger
Journal:  Herz       Date:  2012-06-22       Impact factor: 1.443

Review 7.  [Ivabradine - a new therapeutic option for cardiogenic shock?].

Authors:  Felix Post; Thomas Münzel
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

8.  Structural composition of myocardial infarction scar in middle-aged male and female rats: does sex matter?

Authors:  Yevgen Bogatyryov; Robert J Tomanek; Eduard I Dedkov
Journal:  J Histochem Cytochem       Date:  2013-07-18       Impact factor: 2.479

9.  Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and Ivabradine.

Authors:  Takeshi Kitai; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

10.  Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.

Authors:  Jean-Claude Tardif; Eileen O'Meara; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Luigi Tavazzi; Karl Swedberg
Journal:  Eur Heart J       Date:  2011-08-29       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.